ENANTA PHARMACEUTICALS, INC
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $376.7M
Liabilities Breakdown FY2024
Total Liabilities: $247.8M
Asset Breakdown
Total Assets: $376.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $37.2M | 9.9% |
| Accounts Receivable | $6.6M | 1.8% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $32.7M | 8.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $300.1M | 79.7% |
Liabilities Breakdown
Total Liabilities: $247.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.0M | 3.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $239.8M | 96.8% |